Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats
Authors:
- Dalaal M. AbdallahDADalaal M. Abdallah
- Nadia M. ArafaNANadia M. Arafa
- 1 June 2010
- journal article
- Published by Elsevier in Brain Research
- Vol. 1334, 58-64
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsyEpilepsy Research, 2007
- Modulation of pentylenetetrazole‐induced seizures and oxidative stress parameters by sodium valproate in the absence and presence of N‐acetylcysteineFundamental & Clinical Pharmacology, 2006
- Isolated Idiopathic Hypomagnesemia Presenting as Aphasia and SeizuresPediatric Neurology, 2005
- Effects of some synthetic kynurenines on brain amino acids and nitric oxide after pentylenetetrazole administration to ratsJournal of Pineal Research, 2004
- Thiol redox state (TRS) and oxidative stress in the mouse hippocampus after pentylenetetrazol-induced epileptic seizureNeuroscience Letters, 2004
- Increased phagocytosis and production of reactive oxygen species by neutrophils during magnesium deficiency in rats and inhibition by high magnesium concentrationBritish Journal of Nutrition, 2002
- Competitive NMDA-Receptor Antagonists, LY 235959 and LY 233053, Enhance the Protective Efficacy of Various Antiepileptic Drugs Against Maximal Electroshock-Induced Seizures in MiceEpilepsia, 1996
- In vivo administration of valproate reduces the nerve terminal (synaptosomal) activity of GABA aminotransferase in discrete brain areas of ratsNeuroscience Letters, 1993
- A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compoundsNature, 1993
- Glutathione biosynthesis in human erythrocytesJournal of Clinical Investigation, 1971